Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Hol

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Molecular Neuroscience : MN|December 25, 2007
Protein quality control in neurodegeneration: walking the tight rope between health and diseaseE M Hol, W Scheper
Current Drug Targets. CNS and Neurological Disorders|June 25, 2005
Protein quality control in Alzheimer's disease: a fatal saviourW Scheper, E M Hol
Progress in Neurobiology|January 12, 2011
GFAP in health and diseaseJ Middeldorp, E M Hol
Neurology|March 1, 1995
Cisplatin neuropathyE M Hol, P R Bär
Journal of Neural Transmission. Supplementum|February 10, 2000
Molecular misreading of genes in Down syndrome as a model for the Alzheimer type of neurodegenerationF W van Leeuwen, E M Hol
Annals of the New York Academy of Sciences|October 31, 1994
Dorsal root ganglia as an in vitro model for melanocortin-induced neuritogenesis. Pharmacological and mechanistic aspectsE M Hol, P Sodaar, P R Bär
Annals of the New York Academy of Sciences|October 31, 1994
Involvement of calcium and cAMP in the mechanism of action of two melanocortins: alpha MSH and an ACTH-(4-9) analogueE M Hol, W H Gispen, P R Bär
Annals of the New York Academy of Sciences|August 27, 1993
Trophic effects of melanocortins on neuronal cells in cultureP R Bär, E M Hol, W H Gispen
Peptides|January 1, 1995
ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and neuroprotective actionsE M Hol, W H Gispen, P R Bär
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome systemF W van Leeuwen, E M Hol, D F Fischer
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Molecular Neuroscience : MN|December 25, 2007
Protein quality control in neurodegeneration: walking the tight rope between health and diseaseE M Hol, W Scheper
Current Drug Targets. CNS and Neurological Disorders|June 25, 2005
Protein quality control in Alzheimer's disease: a fatal saviourW Scheper, E M Hol
Progress in Neurobiology|January 12, 2011
GFAP in health and diseaseJ Middeldorp, E M Hol
Neurology|March 1, 1995
Cisplatin neuropathyE M Hol, P R Bär
Journal of Neural Transmission. Supplementum|February 10, 2000
Molecular misreading of genes in Down syndrome as a model for the Alzheimer type of neurodegenerationF W van Leeuwen, E M Hol
Annals of the New York Academy of Sciences|October 31, 1994
Dorsal root ganglia as an in vitro model for melanocortin-induced neuritogenesis. Pharmacological and mechanistic aspectsE M Hol, P Sodaar, P R Bär
Annals of the New York Academy of Sciences|October 31, 1994
Involvement of calcium and cAMP in the mechanism of action of two melanocortins: alpha MSH and an ACTH-(4-9) analogueE M Hol, W H Gispen, P R Bär
Annals of the New York Academy of Sciences|August 27, 1993
Trophic effects of melanocortins on neuronal cells in cultureP R Bär, E M Hol, W H Gispen
Peptides|January 1, 1995
ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and neuroprotective actionsE M Hol, W H Gispen, P R Bär
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome systemF W van Leeuwen, E M Hol, D F Fischer
Pageof 5